The beneficial effect of metformin on anti-tumor immunity was at least partly attributed to its effects on tumor cells by reducing the hypoxia in the tumor microenvironment (13) and reducing the expression of PD-L1 on tumor cells (17). This evidence concerns the gene CD274 and neoplasm.